Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics Inc. (GB:0I3Q)
LSE:0I3Q
Corcept Therapeutics (0I3Q) Share Price & Analysis
0 Followers
0I3Q Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.97 - $30.10
Previous Close$23.14
Volume13.00
Average Volume (3M)171.00
Market Cap
$2.36B
Enterprise Value$1.90B
Total Cash (Recent Filing)$465.06M
Total Debt (Recent Filing)$575.00K
Price to Earnings (P/E)N/A
Beta0.38
Next Earnings
Jul 27, 2023EPS Estimate
$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding101,577,897
10 Day Avg. Volume126
30 Day Avg. Volume171
Standard Deviation0.16
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.51
Price to Sales (P/S)27.07
Price to Cash Flow (P/CF)23.00
P/FCF Ratio23.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.59
Enterprise Value/Gross Profit4.79
Enterprise Value/Ebitda17.71
Forecast
1Y Price Target
$28.00Price Target Upside21.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Corcept Therapeutics News
0I3Q FAQ
What was Corcept Therapeutics Inc.’s price range in the past 12 months?
Corcept Therapeutics Inc. lowest share price was $17.97 and its highest was $30.09 in the past 12 months.
What is Corcept Therapeutics Inc.’s market cap?
Currently, no data Available
When is Corcept Therapeutics Inc.’s upcoming earnings report date?
Corcept Therapeutics Inc.’s upcoming earnings report date is Jul 27, 2023 which is in 52 days.
How were Corcept Therapeutics Inc.’s earnings last quarter?
Corcept Therapeutics Inc. released its earnings results on May 03, 2023. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.199 by -$0.059.
Is Corcept Therapeutics Inc. overvalued?
According to Wall Street analysts Corcept Therapeutics Inc.’s price is currently Undervalued.
Does Corcept Therapeutics Inc. pay dividends?
Corcept Therapeutics Inc. does not currently pay dividends.
What is Corcept Therapeutics Inc.’s EPS estimate?
Corcept Therapeutics Inc.’s EPS estimate is $0.15.
How many shares outstanding does Corcept Therapeutics Inc. have?
Currently, no data Available
What happened to Corcept Therapeutics Inc.’s price movement after its last earnings report?
Corcept Therapeutics Inc. reported an EPS of $0.14 in its last earnings report, missing expectations of $0.199. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Corcept Therapeutics Inc.?
Among the largest hedge funds holding Corcept Therapeutics Inc.’s share is Aristeia Capital LLC. It holds Corcept Therapeutics Inc.’s shares valued at 11M.
---
Corcept Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$28.00 (21.03% Upside)
$28.00 (21.03% Upside)
Blogger Sentiment
Bullish
GB:0I3Q Sentiment 75%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Negative
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.76%
12-Months-Change
Fundamentals
Return on Equity
20.12%
Trailing 12-Months
Asset Growth
31.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Corcept Therapeutics Inc.
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
---
Corcept Therapeutics
―
Mersana Therapeutics
―
MacroGenics
―
Karyopharm Therapeutics
―
Fate Therapeutics
―
---